ClinicalTrials.govpublic full text
Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response
primary central nervous system lymphoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 321717
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.